The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries
Open accessAbstract
The critical role for ADP in arterial thrombogenesis was established by the clinical success of P2Y12 antagonists, currently used at doses that block 40-50% of the P2Y12 on platelets. This study was designed to determine the role of P2Y12 in platelet thrombosis and how its complete absence affects the thrombotic process. P2Y12-null mice were generated by a gene-targeting strategy. Using an in vivo mesenteric artery injury model and real-time continuous analysis of the thrombotic process, we observed that the time for appearance of first thrombus was delayed and that only small, unstable thrombi formed in P2Y12-/- mice without reaching occlusive size, in the absence of aspirin. Platelet adhesion to vWF was impaired in P2Y12-/- platelets. While adhesion to fibrinogen and collagen appeared normal, the platelets in thrombi from P2Y12-/- mice on collagen were less dense and less activated than their WT counterparts. P2Y12-/- platelet activation was also reduced in response to ADP or a PAR-4-activating peptide. Thus, P2Y12 is involved in several key steps of thrombosis: platelet adhesion/activation, thrombus growth, and stability. The data suggest that more aggressive strategies of P2Y12 antagonism will be antithrombotic without the requirement of aspirin cotherapy and may provide benefits even to the aspirin-nonresponder population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Steinhubl, S. R., Berger, P. B., Mann III, J. T., Fry, E. T. A., DeLago, A., Wilmer, C., Topol, E. J., & for the CREDO Investigators (2002) · JAMA · doi:10.1001/jama.288.19.2411 · Cited by 3,078
Mehta, S. R., Yusuf, S., Peters, R. J., Bertrand, M. E., Lewis, B. S., Natarajan, M. K., Malmberg, K., Rupprecht, H.-J., Zhao, F., Chrolavicius, S., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05701-4 · Cited by 2,809
Mehta, S. R., Yusuf, S., & Peters, R. J. G. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00559-7 · Cited by 2,578
Identification of the platelet ADP receptor targeted by antithrombotic drugs
Hollopeter, G., Jantzen, H.-M., Vincent, D., Li, G., England, L., Ramakrishnan, V., Yang, R.-B., Nurden, P., Nurden, A., Julius, D., et al. (2001) · Nature · doi:10.1038/35051599 · Cited by 1,423
Self-citationGum, P. A., Kottke-Marchant, K., Welsh, P. A., White, J., & Topol, E. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)03014-0 · Cited by 1,022
CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism
André, P., Prasad, K. S. S., Denis, C. V., He, M., Papalia, J. M., Hynes, R. O., Phillips, D. R., & Wagner, D. D. (2002) · Nature Medicine · doi:10.1038/nm0302-247 · Cited by 726
Self-citationQuinn, M. J., & Fitzgerald, D. J. (1999) · Circulation · doi:10.1161/01.cir.100.15.1667 · Cited by 496
Ni, H., Denis, C. V., Subbarao, S., Degen, J. L., Sato, T. N., Hynes, R. O., & Wagner, D. D. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9896 · Cited by 492
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis
Angelillo-Scherrer, A., de Frutos, P. G., Aparicio, C., Melis, E., Savi, P., Lupu, F., Arnout, J., Dewerchin, M., Hoylaerts, M. F., Herbert, J.-M., et al. (2001) · Nature Medicine · doi:10.1038/84667 · Cited by 441 · cited 1×
“As platelets release thrombogenic mediators such as CD40L and Gas6 upon activation (28, 29), this could further reduce the thrombogenicity of a P2Y12 growing thrombus.”
BackgroundADP Receptors of Platelets and their Inhibition
Gachet, C. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616220 · Cited by 415
Foster, C. J., Prosser, D. M., Agans, J. M., Zhai, Y., Smith, M. D., Lachowicz, J. E., Zhang, F. L., Gustafson, E., Monsma, F. J., Wiekowski, M. T., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12242 · Cited by 415
A revised model of platelet aggregation
Kulkarni, S., Dopheide, S. M., Yap, C. L., Ravanat, C., Freund, M., Mangin, P., Heel, K. A., Street, A., Harper, I. S., Lanza, F., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7569 · Cited by 347
Pro-coagulant state resulting from high levels of soluble P-selectin in blood
André, P., Hartwell, D., Hrachovinová, I., Saffaripour, S., & Wagner, D. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250475997 · Cited by 317
Self-citationAndré, P., Denis, C. V., Ware, J., Saffaripour, S., Hynes, R. O., Ruggeri, Z. M., & Wagner, D. D. (2000) · Blood · doi:10.1182/blood.v96.10.3322 · Cited by 308
Cadroy, Y., Bossavy, J.-P., Thalamas, C., Sagnard, L., Sakariassen, K., & Boneu, B. (2000) · Circulation · doi:10.1161/01.cir.101.24.2823 · Cited by 266
Hermann, A., Rauch, B. H., Braun, M., Schrör, K., & Weber, A.-A. (2001) · Platelets · doi:10.1080/09537100020031207 · Cited by 255
Yang, J., Wu, J., Kowalska, M. A., Dalvi, A., Prevost, N., O'Brien, P. J., Manning, D., Poncz, M., Lucki, I., Blendy, J. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180194597 · Cited by 199
Activation of Rap1B by Gi Family Members in Platelets
Woulfe, D., Jiang, H., Mortensen, R., Yang, J., & Brass, L. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202212200 · Cited by 192
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention
Steinhubl, S. R., Berger, P. B., & Mann, J. T. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00075-8 · Cited by 191
Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39.
Gayle, R. B., Maliszewski, C. R., Gimpel, S. D., Schoenborn, M. A., Caspary, R. G., Richards, C., Brasel, K., Price, V, Drosopoulos, J. H., Islam, N., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1753 · Cited by 187
Kim, S., Foster, C., Lecchi, A., Quinton, T. M., Prosser, D. M., Jin, J., Cattaneo, M., & Kunapuli, S. P. (2002) · Blood · doi:10.1182/blood.v99.10.3629 · Cited by 184
Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain
Pinsky, D. J., Broekman, M. J., Peschon, J. J., Stocking, K. L., Fujita, T., Ramasamy, R., Connolly, E. S., Huang, J., Kiss, S., Zhang, Y., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci10649 · Cited by 176
Impaired activation of murine platelets lacking Gαi2
Jantzen, H.-M., Milstone, D. S., Gousset, L., Conley, P. B., & Mortensen, R. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12818 · Cited by 161
Self-citationRole of Fc receptor γ-chain in platelet glycoprotein Ib–mediated signaling
Wu, Y., Suzuki‐Inoue, K., Satoh, K., Asazuma, N., Yatomi, Y., Berndt, M. C., & Ozaki, Y. (2001) · Blood · doi:10.1182/blood.v97.12.3836 · Cited by 128
Keularts, I. M. L. W., van Gorp, R. M. A., Feijge, M. A. H., Vuist, W. M. J., & Heemskerk, J. W. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1763 · Cited by 96
Shattil, S., Budzynski, A. Z., & Scrutton, M. (1989) · Blood · doi:10.1182/blood.v73.1.150.150 · Cited by 88
Bossavy, J.-P., Thalamas, C., Sagnard, L., et al. (1998) · Blood · doi:10.1182/blood.v92.5.1518 · Cited by 76
Increased thrombogenesis and embolus formation in mice lacking glycoprotein V
Ni, H., Ramakrishnan, V., Ruggeri, Z. M., Papalia, J. M., Phillips, D. R., & Wagner, D. D. (2001) · Blood · doi:10.1182/blood.v98.2.368 · Cited by 72
Self-citationQuinton, T. M., Özdener, F., Dangelmaier, C., Daniel, J. L., & Kunapuli, S. P. (2002) · Blood · doi:10.1182/blood.v99.9.3228 · Cited by 57
Cited by
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
The P2Y12 receptor regulates microglial activation by extracellular nucleotides
Haynes, S. E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M. E., Gan, W.-B., & Julius, D. (2006) · Nature Neuroscience · doi:10.1038/nn1805 · Cited by 1,542
Abbracchio, M. P., Burnstock, G., Boeynaems, J.-M., Barnard, E. A., Boyer, J. L., Kennedy, C., Knight, G. E., Fumagalli, M., Gachet, C., Jacobson, K. A., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.3 · Cited by 1,281
Negative feedback control of neuronal activity by microglia
Badimon, A., Strasburger, H. J., Ayata, P., Chen, X., Nair, A., Ikegami, A., Hwang, P., Chan, A. T., Graves, S. M., Uweru, J. O., et al. (2020) · Nature · doi:10.1038/s41586-020-2777-8 · Cited by 979
Metadata
- Authors
- André, P., Delaney, S. M., LaRocca, T., Vincent, D., DeGuzman, F., Jurek, M., Koller, B., Phillips, D. R., & Conley, P. B.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-08-01
- Volume
- 112
- Issue
- 3
- Pages
- 398-406
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2144095528
- Cited by
- 359
- References
- 31
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.